Inventor · disambiguated record
Ari E. Friedland
Also filed as: FRIEDLAND ARI · FRIEDLAND ARI E
12 granted patents·14 pending applications·48 citations·filing 2005–2024
88Inventor score
Files withEDITAS MEDICINE INC20NCHROMA BIO INC3CHROMA MEDICINE INC1COLLINS JAMES J1JUNO THERAPEUTICS INC1
Top patents by PatentIndex Score
26 records- 0195US9963719B1Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNAEDITAS MEDICINE INC·Filed 2017·Granted May 8, 2018·15 cites·14 claims
- 0292US10006054B1Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNAEDITAS MEDICINE INC·Filed 2018·Granted Jun 26, 2018·6 cites·18 claims
- 0389US8182804B1Engineered enzymatically active bacteriophages and methods of uses thereofCOLLINS JAMES J·Filed 2005·Granted May 22, 2012·22 cites·18 claims
- 0486US12264331B2Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNAEDITAS MEDICINE INC·Filed 2023·Granted Apr 1, 2025·0 cites·26 claims
- 0584US11028411B2Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNAEDITAS MEDICINE INC·Filed 2019·Granted Jun 8, 2021·1 cites·28 claims
- 0683US11001844B2CRISPR/Cas-related methods and compositions for treating herpes simplex virusEDITAS MEDICINE INC·Filed 2018·Granted May 11, 2021·2 cites·26 claims
- 0782US11242525B2CRISPR/CAS-related methods and compositions for treating sickle cell diseaseEDITAS MEDICINE INC·Filed 2015·Granted Feb 8, 2022·2 cites·28 claims
- 0878US11692205B2Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNAEDITAS MEDICINE INC·Filed 2021·Granted Jul 4, 2023·0 cites·6 claims
- 0975US2024294917A1Crispr/cas-related methods and compositions for treating herpes simplex virus type 1 (hsv-1)EDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 1070US10494649B2Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNAEDITAS MEDICINE INC·Filed 2018·Granted Dec 3, 2019·0 cites·6 claims
- 1169US11834649B2CRISPR/CAS-related methods and compositions for treating herpes simplex virusEDITAS MEDICINE INC·Filed 2021·Granted Dec 5, 2023·0 cites·21 claims
- 1268US2023026726A1Crispr/cas-related methods and compositions for treating sickle cell diseaseEDITAS MEDICINE INC·Filed 2022·Application pending·0 cites
- 1364US2022106600A1Crispr-cas-related methods, compositions and components for cancer immunotherapyEDITAS MEDICINE INC·Filed 2021·Application pending·0 cites
- 1463US2024076678A1Compositions and methods for epigenetic editingCHROMA MEDICINE INC·Filed 2023·Application pending·0 cites
- 1562US2021380987A1Crispr/cas-related methods and compositions for treating cystic fibrosisEDITAS MEDICINE INC·Filed 2021·Application pending·0 cites
- 1660US11390861B2CRISPR/cas-related methods and compositions for treating herpes simplex virusEDITAS MEDICINE INC·Filed 2019·Granted Jul 19, 2022·0 cites·16 claims
- 1760US2025197818A1Compositions and methods for epigenetic editingNCHROMA BIO INC·Filed 2024·Application pending·0 cites
- 1857US2025387514A1Compositions and methods for epigenetic regulation of trac expressionNCHROMA BIO INC·Filed 2023·Application pending·0 cites
- 1957US2025387518A1Compositions and methods for epigenetic regulation of b2m expressionNCHROMA BIO INC·Filed 2023·Application pending·0 cites
- 2054US11028394B2CRISPR/CAS-related methods and compositions for treating cystic fibrosisEDITAS MEDICINE INC·Filed 2016·Granted Jun 8, 2021·0 cites·9 claims
- 2154US2020392208A1Crispr/cas-related methods and compositions for treating herpes simplex virus (hsv) related keratitisEDITAS MEDICINE INC·Filed 2020·Application pending·0 cites
- 2251US2017073685A1Crispr/cas-related methods and compositions for treating herpes simplex virus type 1 (hsv-1)EDITAS MEDICINE INC·Filed 2016·Application pending·0 cites
- 2347US2017175128A1Crispr-cas-related methods, compositions and components for cancer immunotherapyEDITAS MEDICINE INC·Filed 2015·Application pending·0 cites
- 2442US2018236103A1Crispr/cas-related methods and compositions for treating hepatitis b virusEDITAS MEDICINE INC·Filed 2018·Application pending·0 cites
- 2541US2017007679A1Crispr/cas-related methods and compositions for treating hiv infection and aidsEDITAS MEDICINE INC·Filed 2016·Application pending·0 cites
- 2637US2019136230A1Genetically engineered cells and methods of making the sameJUNO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ari E. Friedland files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →